Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Effect of the adenosine A2A receptor antagonist MSX-3 on motivational disruptions of maternal behavior induced by dopamine antagonism in the early postpartum rat.

Pereira M, Farrar AM, Hockemeyer J, Müller CE, Salamone JD, Morrell JI.

Psychopharmacology (Berl). 2011 Jan;213(1):69-79. doi: 10.1007/s00213-010-2015-4. Epub 2010 Sep 17.

2.

Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing.

Farrar AM, Pereira M, Velasco F, Hockemeyer J, Müller CE, Salamone JD.

Psychopharmacology (Berl). 2007 Apr;191(3):579-86. Epub 2006 Oct 27.

PMID:
17072593
3.

Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats.

Ishiwari K, Madson LJ, Farrar AM, Mingote SM, Valenta JP, DiGianvittorio MD, Frank LE, Correa M, Hockemeyer J, Müller C, Salamone JD.

Behav Brain Res. 2007 Mar 28;178(2):190-9. Epub 2006 Dec 21.

4.

The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure.

Mott AM, Nunes EJ, Collins LE, Port RG, Sink KS, Hockemeyer J, Müller CE, Salamone JD.

Psychopharmacology (Berl). 2009 May;204(1):103-12. doi: 10.1007/s00213-008-1441-z. Epub 2009 Jan 9.

5.

The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists.

Worden LT, Shahriari M, Farrar AM, Sink KS, Hockemeyer J, Müller CE, Salamone JD.

Psychopharmacology (Berl). 2009 Apr;203(3):489-99. doi: 10.1007/s00213-008-1396-0. Epub 2008 Dec 2.

6.
7.

Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice.

Pardo M, López-Cruz L, Valverde O, Ledent C, Baqi Y, Müller CE, Salamone JD, Correa M.

Behav Brain Res. 2013 Jun 15;247:217-26. doi: 10.1016/j.bbr.2013.03.035. Epub 2013 Apr 1.

PMID:
23557694
8.

Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism.

Salamone JD, Farrar AM, Font L, Patel V, Schlar DE, Nunes EJ, Collins LE, Sager TN.

Behav Brain Res. 2009 Jul 19;201(1):216-22. doi: 10.1016/j.bbr.2009.02.021. Epub 2009 Mar 3.

9.

c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.

Zhao C, Li M.

Neuroscience. 2010 Apr 14;166(4):1043-55. doi: 10.1016/j.neuroscience.2010.01.023. Epub 2010 Jan 22.

10.

Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity.

Collins LE, Galtieri DJ, Collins P, Jones SK, Port RG, Paul NE, Hockemeyer J, Müller CE, Salamone JD.

Behav Brain Res. 2010 Aug 25;211(2):148-55. doi: 10.1016/j.bbr.2010.03.003. Epub 2010 Mar 6.

PMID:
20211657
11.

Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors.

Farrar AM, Segovia KN, Randall PA, Nunes EJ, Collins LE, Stopper CM, Port RG, Hockemeyer J, Müller CE, Correa M, Salamone JD.

Neuroscience. 2010 Apr 14;166(4):1056-67. doi: 10.1016/j.neuroscience.2009.12.056. Epub 2010 Jan 20.

PMID:
20096336
12.

Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism.

Nunes EJ, Randall PA, Santerre JL, Given AB, Sager TN, Correa M, Salamone JD.

Neuroscience. 2010 Sep 29;170(1):268-80. doi: 10.1016/j.neuroscience.2010.05.068. Epub 2010 Jun 25.

13.

The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.

Correa M, Wisniecki A, Betz A, Dobson DR, O'Neill MF, O'Neill MJ, Salamone JD.

Behav Brain Res. 2004 Jan 5;148(1-2):47-54.

PMID:
14684247
14.

Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice.

Pardo M, Lopez-Cruz L, Valverde O, Ledent C, Baqi Y, Müller CE, Salamone JD, Correa M.

Neuropharmacology. 2012 Apr;62(5-6):2068-77. doi: 10.1016/j.neuropharm.2011.12.033. Epub 2012 Jan 10.

PMID:
22261384
15.

Choosing voluntary exercise over sucrose consumption depends upon dopamine transmission: effects of haloperidol in wild type and adenosine A₂AKO mice.

Correa M, Pardo M, Bayarri P, López-Cruz L, San Miguel N, Valverde O, Ledent C, Salamone JD.

Psychopharmacology (Berl). 2016 Feb;233(3):393-404. doi: 10.1007/s00213-015-4127-3. Epub 2015 Nov 10.

PMID:
26554387
17.
18.

Sedation and disruption of maternal motivation underlie the disruptive effects of antipsychotic treatment on rat maternal behavior.

Zhao C, Li M.

Pharmacol Biochem Behav. 2009 Mar;92(1):147-56. doi: 10.1016/j.pbb.2008.11.006. Epub 2008 Nov 17.

19.

Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats.

Chen W, Zhang Q, Su W, Zhang H, Yang Y, Qiao J, Sui N, Li M.

Pharmacol Biochem Behav. 2014 Feb;117:25-33. doi: 10.1016/j.pbb.2013.11.034. Epub 2013 Dec 7.

20.

SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

Bonaccorso S, Meltzer HY, Li Z, Dai J, Alboszta AR, Ichikawa J.

Neuropsychopharmacology. 2002 Sep;27(3):430-41.

Supplemental Content

Support Center